Literature DB >> 1754520

Current views on aetiology and management of haemolytic uraemic syndrome.

M M Fitzpatrick1, M J Dillon.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1754520      PMCID： PMC2399050          DOI： 10.1136/pgmj.67.790.707

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  33 in total

1.  Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology.

Authors:  C Loirat; E Sonsino; N Hinglais; J P Jais; P Landais; J Fermanian
Journal:  Pediatr Nephrol       Date:  1988-07       Impact factor: 3.714

Review 2.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

3.  Cytopathic effect of verotoxin on endothelial cells.

Authors:  J Kavi; I Chant; M Maris; P E Rose
Journal:  Lancet       Date:  1987-10-31       Impact factor: 79.321

4.  Pathogenesis of haemolytic uraemic syndrome.

Authors:  T G Obrig; P J Del Vecchio; M A Karmali; M Petric; T P Moran; T K Judge
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

5.  Two distinct toxins active on Vero cells from Escherichia coli O157.

Authors:  S M Scotland; H R Smith; B Rowe
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

6.  A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home.

Authors:  A O Carter; A A Borczyk; J A Carlson; B Harvey; J C Hockin; M A Karmali; C Krishnan; D A Korn; H Lior
Journal:  N Engl J Med       Date:  1987-12-10       Impact factor: 91.245

7.  Hemolytic uremic syndrome in families.

Authors:  B S Kaplan; R W Chesney; K N Drummond
Journal:  N Engl J Med       Date:  1975-05-22       Impact factor: 91.245

8.  Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.

Authors:  C A Lingwood; H Law; S Richardson; M Petric; J L Brunton; S De Grandis; M Karmali
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

9.  Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresis.

Authors:  G Garibotto; N Acquarone; S Saffioti; G Deferrari; B Villaggio; F Ferrario
Journal:  Nephron       Date:  1989       Impact factor: 2.847

10.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226
View more
  1 in total

1.  The haemolytic uraemic syndrome in patients with AIDS.

Authors:  P Kelleher; A Severn; C Tomson; S Lucas; J Parkin; A Pinching; R Miller
Journal:  Genitourin Med       Date:  1996-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.